The report analyzes and forecasts the Autologous matrix-induced chondrogenesis market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2019 to 2026. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level. For the region and all segments, the sales, revenue and their market share, growth rate are key research objects; we can research the manufacturers' sales, price, revenue, cost and gross profit and their changes. What's more, we will display the main consumers, raw material manufacturers, distributors, etc.
This report first introduces the background of Autologous matrix-induced chondrogenesis, including the definition, classification, application, industrial chain structure, industry overview, national policy and planning analysis of the industry, and the latest dynamic analysis. With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Autologous matrix-induced chondrogenesis companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Autologous matrix-induced chondrogenesis upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of Autologous matrix-induced chondrogenesis and consumption, major regions and consumption, major global producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global Autologous matrix-induced chondrogenesis market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the Autologous matrix-induced chondrogenesis market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of Autologous matrix-induced chondrogenesis market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
Competitive Dynamics
The report also profiles major players in this market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Anika Therapeutics, Inc., Arthro-Kinetics, B. Braun Melsungen AG, BioTissue AG, CartiHeal, Geistlich Pharma AG, JRI Orthopaedics Ltd., Matricel GmbH, Smith & Nephew plc and Zimmer Biomet Holdings.
The global autologous matrix-induced chondrogenesis market has been segmented as follows:
Global Autologous Matrix-Induced Chondrogenesis Market, by Material
Global Autologous Matrix-Induced Chondrogenesis Market, by Geography
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding.
Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
The study objectives of this report are:
Section - 1 Preface
1.1 Report Scope and Market Segmentation
1.2 Research Highlights
Section - 2 Assumptions and Research Methodology
2.1 Assumptions and Acronyms Used
2.2 Research Methodology
Section-3 Executive Summary
3.1 Global AMIC Market: Market Snapshot
3.2 Global AMIC Market : Opportunity Map
Section-4 Market Overview
4.1 Global AMIC Market : Key Industry Developments
Section-5 Market Dynamics
5.1 Drivers and Restraints Snapshot Analysis
5.1.2 Drivers
5.1.2.1 Increasing Demand for Minimally Invasive Procedures
5.1.2.2 Economically Efficient
5.1.2.3 Rising Prevalence of Bone and Joint Disorders
5.1.2.4 Aging Population
5.1.2.5 Surge in Sports Injuries
5.1.2.6 Reduces Life Risk and Faster Recovery
5.1.3 Restraints
5.1.3.1 Lack of Efficient Reimbursement System
5.1.3.2 Lack of Extensive Clinical Data
5.1.4 Opportunity Analysis
5.1.4.1 Emerging Economies to Offer Sustained Growth Opportunities
5.1.4.2 Extending Distribution Network by Partnership/Acquisitions
5.2 Global AMIC Market Revenue Projection
5.3 Porter’s Five Forces Analysis
5.4 Value Chain Analysis
5.5 AMIC Market Outlook
Section-6 AMIC Market Analysis By Material
6.1 Key Findings
6.2 Introduction
6.3 Global AMIC Market Value Share Analysis, By Product Type
6.4 Global AMIC Market Forecast By Product Type
6.4.1 Hyaluronic Acid
6.4.2 Collagen
6.4.3 Polyethylene glycol (PEG)
6.4.4 Poly lactic-co-glycolic acid (PGLA)
6.4.5 Others
6.5 Global AMIC Market Attractiveness Analysis By Material
Section-7 Global AMIC Market Analysis By Region
7.1 Global Regulatory Scenario
7.2 Global AMIC Market Value Share Analysis, By Region
7.3 Global AMIC Market Forecast, By Region
7.4 Global AMIC Market Attractiveness Analysis, By Region Type
Section-8 North America AMIC Market Analysis
8.1 Key Findings
8.2 North America AMIC Market Overview
8.3 North America Market Value Share Analysis, By Material
8.3.1 North America Market Forecast By Material
8.4 North America Market Forecast By Country
8.5 North America Market Attractiveness Analysis
8.6 North America Market Trends
Section-9 Europe AMIC Market Analysis
9.1 Key Findings
9.2 Europe ABC Market Overview
9.3 Europe Market Value Share Analysis, By Material
9.3.1 Europe Market Forecast By Material
9.4 Europe Market Forecast By Country
9.5 Europe Market Attractiveness Analysis
9.6 Europe Market Trends
Section-10 Asia Pacific AMIC Market Analysis
10.1 Key Findings
10.2 Asia Pacific AMIC Market Overview
10.3 Asia Pacific Market Value Share Analysis, By Material
10.3.1 Asia Pacific Market Forecast By Material
10.4 Asia Pacific Market Forecast By Country
10.5 Asia Pacific Market Attractiveness Analysis
10.6 Asia Pacific Market Trends
Section-11 Latin America AMIC Market Analysis
11.1 Key Findings
11.2 Latin America AMIC Market Overview
11.3 Latin America Market Value Share Analysis, By Material
11.3.1 Latin America Market Forecast By Material
11.4 Latin America Market Forecast By Country
11.5 Latin America Market Attractiveness Analysis
11.6 Latin America Market Trends
Section-12 Middle East and Africa AMIC Market Analysis
12.1 Key Findings
12.2 Middle East and Africa AMIC Market Overview
12.3 Middle East and Africa Market Value Share Analysis, By Material
12.3.1 Middle East and Africa Market Forecast By Material
12.4 Middle East and Africa Market Forecast By Country
12.5 Middle East and Africa Market Attractiveness Analysis
Section-13 Competition Landscape
13.1. Competition Matrix
13.2. Company Profiles
13.2.1. Anika Therapeutics, Inc.
13.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.1.2. Financial Overview
13.2.1.3. Product Portfolio
13.2.1.4. SWOT Analysis
13.2.1.5. Strategic Overview
13.2.2 Arthro-Kinetics
13.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.2.2. Financial Overview
13.2.2.3. Product Portfolio
13.2.2.4. SWOT Analysis
13.2.2.5. Strategic Overview
13.2.3 B. Braun Melsungen AG
13.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.3.2. Financial Overview
13.2.3.3. Product Portfolio
13.2.3.4. SWOT Analysis
13.2.3.5. Strategic Overview
13.2.4 BioTissue AG
13.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.4.2. Financial Overview
13.2.4.3. Product Portfolio
13.2.4.4. SWOT Analysis
13.2.4.5. Strategic Overview
13.2.5 CartiHeal
13.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.5.2. Financial Overview
13.2.5.3. Product Portfolio
13.2.5.4. SWOT Analysis
13.2.5.5. Strategic Overview
13.2.6 Geistlich Pharma AG
13.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.6.2. Financial Overview
13.2.6.3. Product Portfolio
13.2.6.4. SWOT Analysis
13.2.6.5. Strategic Overview
13.2.7 JRI Orthopaedics Ltd.
13.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.7.2. Financial Overview
13.2.7.3. Product Portfolio
13.2.7.4. SWOT Analysis
13.2.7.5. Strategic Overview
13.2.8 Matricel GmbH
13.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.8.2. Financial Overview
13.2.8.3. Product Portfolio
13.2.8.4. SWOT Analysis
13.2.8.5. Strategic Overview
13.2.9 Smith & Nephew plc
13.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.9.2. Financial Overview
13.2.9.3. Product Portfolio
13.2.9.4. SWOT Analysis
13.2.9.5. Strategic Overview
13.2.10 Zimmer Biomet Holdings
13.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.10.2. Financial Overview
13.2.10.3. Product Portfolio
13.2.10.4. SWOT Analysis
13.2.10.5. Strategic Overview
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers